Characterization of a vitamin D3-resistant MCF-7 cell line

Endocrinology

Volumn 137, Issue 2, 1996, Pages 400-409

  Narvaez, Carmen J ^a   Vanweelden, Kathryn ^a   Byrne, Ian ^a   Welsh, Joellen ^a  

^a Adirondack Biomedical Research Institute Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; CALCITRIOL; CATHEPSIN; CLUSTERIN; ANTIESTROGEN; CALCITRIOL RECEPTOR; CATHEPSIN B; CHAPERONE; CLU PROTEIN, HUMAN; COLECALCIFEROL; COMPLEMENT INHIBITOR; DRUG DERIVATIVE; GLYCOPROTEIN; TUMOR PROTEIN; VITAMIN D;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DIAGNOSIS; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REGULATORY MECHANISM; VITAMIN METABOLISM; BREAST TUMOR; CELL CULTURE; CELL DEATH; CELL DIVISION; DRUG RESISTANCE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST NEOPLASMS; CALCITRIOL; CATHEPSIN B; CELL DEATH; CELL DIVISION; CHOLECALCIFEROL; CLUSTERIN; COMPLEMENT INACTIVATOR PROTEINS; DRUG RESISTANCE, NEOPLASM; ESTROGEN ANTAGONISTS; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 85047676031     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.2.8593782     Document Type: Article

References (31)

1. 3 metabolites. Cancer Res 43:4443-4447
2. Chouvet C, Berger U, Coombes RC 1986 1,25 Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 24:373-376
3. Colston K, Chander SK, Mackay AG, Coombes RC 1992 Effects of synthetic vitamin D analogs on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 44:693-702
4. 3 receptors: structure and function in transcription. Annu Rev Nutr 11:189-216
5. 3 in MCF-7 breast cancer cells. In: Norman AW, Bouillon R, Thomasett M (eds) Proceedings of the Ninth Workshop on Vitamin D. DeGruyter, Berlin, pp 000-000
6. 3: coordinate regulator of active cell death and proliferation in MCF-7 breast cancer cells. In: Schering Foundation Workshop. Springer Verlag, Berlin, vol 14:181-200
7. Welsh JE 1994 Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 72:537-545
8. Tenniswood MP, Taillefer D, Lakins J, Guenette RS, Mooibroek M, Daehlin L, Welsh JE 1994 Control of gene expression during apoptosis in hormone dependent tissues. In: Tomei LD, Cope FO (eds) Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, vol 2:283-311
9. Guenette RS, Corbeil H, Leger J, Wong K, Mezl V, Mooibroek M, Tenniswood M 1994 Induction of gene expression during involution of the lactating mammary gland of the rat. J Mol Endocrinol 12:47-60
10. 3. Kidney Int 45:95-102
11. 3 and TGFβ in IEC-6 cells. In: Norman AW, Bouillon R, Thomasett M (eds) Proceedings of the Ninth Workshop on Vitamin D. DeGruyter, Berlin, pp 000-000
12. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SRT 1994 Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31:191-202
13. 3 binding and calbindin D-28K in renal (MDBK) cells. Mol Cell Endocrinol 83:143-151
14. Wang TTY, Phang JM 1995 Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55:2487-2489
15. s sensitizes MCF-7 cells to chemotherapy induced apoptosis. Cancer Res 55:2507-2510
16. 3 receptors. Cell 65:1255-1266
17. Guenette RS, Mooibroek M, Wong K, Wong P, Tenniswood M 1994 Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur J Biochem 226:311-321
18. Lanzerotti RH, Gullino PM 1972 Activities and quantities of lysosomal enzymes during mammary tumor regression. Cancer Res 32:2679-2685
19. Kyprianou N, English H, Davidson N, Isaacs J 1991 Programmed cell death during regression of the MCF-7 human breast cancer following esrrogen ablation. Cancer Res 51:162-166
20. Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL 1993 Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412-1418
21. 3 derivatives and breast cancer. In: Schering Foundation Workshop. Springer Verlag, Berlin, vol 14:201-224
22. 3 analogues:a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42:1569-1575
23. Studzinski GP, McLane JA, Uskokovic MR 1993 Signalling pathways for vitamin D induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryotic Gene Exp 3:279-312
24. Bardon S, Vignon F, Montcourrier P, Rochefort H 1987 Steroid mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res 47:1441-1448
25. Blobe GC, Sachs CW, Wasiuddin AK, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL, Hannun YA 1993 Selective regulation of expression of protein kinase C (PKC) isozymes in multidrug resistant MCF-7 cells. J Biol Chem 268:658-664
26. 3. AACR Special Conference on Mechanism of Action of Retinoids, Vitamin D and Steroid Hormones, Banff, Alberta, Canada, 1993
27. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558
28. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo J, Hunziker W 1993 Two nuclear signalling pathways for vitamin D. Nature 361:657-660
29. 3 receptor in the absence of retinoid X receptor. Mol Endocrinol 8:265-273
30. 3 stimulated osteocalcin gene transcription by tumor necrosis factor α: structural determinants within the vitamin D response elements. Endocrinology 134:2524-2531
31. 3. Proc Natl Acad Sci USA 89:8097-8101